Title | Type | SJR | H index | Total Docs. (2007) | Total Docs. (3years) | Total Refs. (2007) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2007) | %Female (2007) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
137 | American Journal of PharmacoGenomics | journal | 0.858 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
136 | Frontiers in Medicinal Chemistry | book series | 0.107 Q4 | 7 | 0 | 27 | 0 | 5 | 26 | 0.19 | 0.00 | 0.00 | |
135 | Gene Therapy and Regulation | journal | 0.249 Q4 | 7 | 6 | 16 | 509 | 26 | 13 | 0.00 | 84.83 | 20.00 | |
134 | Medicinal Chemistry Reviews - Online | journal | 0.207 Q4 | 7 | 0 | 46 | 0 | 22 | 46 | 0.48 | 0.00 | 0.00 | |
133 | Frontiers in Drug Design and Discovery | book series | 0.124 Q4 | 9 | 23 | 18 | 2910 | 5 | 17 | 0.28 | 126.52 | 18.31 | |
132 | Drug Design Reviews Online | journal | 0.213 Q4 | 11 | 0 | 48 | 0 | 22 | 48 | 0.46 | 0.00 | 0.00 | |
131 | Current Cancer Therapy Reviews | journal | 0.210 Q4 | 17 | 31 | 31 | 3015 | 12 | 30 | 0.39 | 97.26 | 39.62 | |
130 | Gene Therapy and Molecular Biology | journal | 0.172 Q4 | 18 | 32 | 30 | 1814 | 11 | 30 | 0.37 | 56.69 | 36.62 | |
129 | Current Enzyme Inhibition | journal | 0.245 Q4 | 19 | 25 | 29 | 3343 | 22 | 29 | 0.76 | 133.72 | 38.46 | |
128 | Pteridines | journal | 0.278 Q4 | 19 | 14 | 51 | 466 | 31 | 48 | 0.59 | 33.29 | 45.45 | |
127 | BMC Chemical Biology | journal | 0.740 Q3 | 21 | 2 | 8 | 91 | 17 | 8 | 1.83 | 45.50 | 25.00 | |
126 | Journal of Stem Cells | journal | 0.196 Q4 | 21 | 20 | 22 | 1260 | 12 | 21 | 0.55 | 63.00 | 33.33 | |
125 | Turkish Journal of Pharmaceutical Sciences | journal | 0.112 Q4 | 22 | 15 | 15 | 365 | 2 | 15 | 0.13 | 24.33 | 39.68 | |
124 | Bollettino Chimico Farmaceutico | journal | 0.131 Q4 | 27 | 0 | 57 | 0 | 6 | 48 | 0.00 | 0.00 | 0.00 | |
123 | Current Pharmaceutical Analysis | journal | 0.435 Q3 | 27 | 28 | 32 | 2492 | 32 | 32 | 1.00 | 89.00 | 31.87 | |
122 | Drug Discovery Today: Disease Mechanisms | journal | 0.257 Q4 | 28 | 42 | 220 | 2084 | 110 | 203 | 0.42 | 49.62 | 27.63 | |
121 | Expert Opinion on Medical Diagnostics | journal | 28 | 48 | 0 | 3892 | 0 | 0 | 0.00 | 81.08 | 24.17 | ||
120 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.120 Q4 | 29 | 6 | 23 | 121 | 3 | 21 | 0.13 | 20.17 | 0.00 | |
119 | Genetic Vaccines and Therapy | journal | 0.688 Q3 | 30 | 12 | 29 | 437 | 56 | 29 | 1.83 | 36.42 | 55.22 | |
118 | Drug Discovery Today: Therapeutic Strategies | journal | 0.366 Q4 | 31 | 42 | 215 | 1785 | 177 | 204 | 0.67 | 42.50 | 32.99 | |
117 | MCB Molecular and Cellular Biomechanics | journal | 0.451 Q3 | 31 | 18 | 110 | 608 | 122 | 108 | 0.80 | 33.78 | 21.31 | |
116 | Current Computer-Aided Drug Design | journal | 0.210 Q4 | 32 | 24 | 28 | 2269 | 16 | 26 | 0.57 | 94.54 | 36.23 | |
115 | Drug Discovery Today: Disease Models | journal | 0.205 Q4 | 33 | 36 | 175 | 1364 | 58 | 164 | 0.22 | 37.89 | 32.50 | |
114 | Drugs in Context | journal | 0.101 Q4 | 36 | 11 | 48 | 265 | 0 | 36 | 0.00 | 24.09 | 20.00 | |
113 | Personalized Medicine | journal | 0.209 Q4 | 36 | 52 | 42 | 1997 | 22 | 36 | 0.52 | 38.40 | 38.46 | |
112 | Yaoxue Xuebao | journal | 0.303 Q4 | 36 | 243 | 693 | 3896 | 421 | 693 | 0.61 | 16.03 | 40.29 | |
111 | Letters in Drug Design and Discovery | journal | 0.261 Q4 | 37 | 99 | 213 | 3076 | 129 | 213 | 0.61 | 31.07 | 33.33 | |
110 | Journal of Biological Sciences (discontinued) | journal | 0.118 Q4 | 38 | 264 | 199 | 6776 | 40 | 199 | 0.20 | 25.67 | 24.64 | |
109 | Progress in Medicinal Chemistry | journal | 0.981 Q2 | 38 | 5 | 23 | 777 | 54 | 20 | 2.88 | 155.40 | 16.67 | |
108 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.323 Q4 | 39 | 28 | 75 | 3522 | 56 | 72 | 0.63 | 125.79 | 35.44 | |
107 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.105 Q4 | 40 | 11 | 44 | 0 | 2 | 44 | 0.00 | 0.00 | 24.39 | |
106 | Drugs under Experimental and Clinical Research | journal | 0.379 Q4 | 41 | 0 | 66 | 0 | 111 | 66 | 1.47 | 0.00 | 0.00 | |
105 | Clinical Proteomics | journal | 0.446 Q3 | 42 | 6 | 35 | 165 | 49 | 34 | 0.20 | 27.50 | 18.75 | |
104 | Future Cardiology | journal | 0.203 Q4 | 43 | 74 | 77 | 3251 | 16 | 70 | 0.21 | 43.93 | 22.22 | |
103 | Cellular Oncology | journal | 1.343 Q2 | 44 | 43 | 98 | 1645 | 254 | 73 | 2.65 | 38.26 | 36.44 | |
102 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.866 Q3 | 45 | 32 | 115 | 3098 | 306 | 108 | 2.62 | 96.81 | 35.11 | |
101 | International Journal of Peptide Research and Therapeutics | journal | 0.453 Q3 | 45 | 57 | 72 | 2253 | 76 | 70 | 1.06 | 39.53 | 32.89 | |
100 | Progress in Drug Research | book series | 0.481 Q3 | 46 | 13 | 23 | 993 | 33 | 21 | 1.43 | 76.38 | 15.38 | |
99 | Virologica Sinica | journal | 0.112 Q4 | 47 | 66 | 123 | 1747 | 10 | 123 | 0.08 | 26.47 | 33.85 | |
98 | AIDS Research and Therapy | journal | 0.695 Q3 | 49 | 28 | 42 | 1074 | 76 | 41 | 1.80 | 38.36 | 48.46 | |
97 | Journal of Asian Natural Products Research | journal | 0.317 Q4 | 51 | 114 | 252 | 1350 | 171 | 252 | 0.65 | 11.84 | 28.54 | |
96 | Nucleosides, Nucleotides and Nucleic Acids | journal | 0.381 Q4 | 53 | 274 | 625 | 3236 | 510 | 625 | 0.78 | 11.81 | 33.73 | |
95 | SAR and QSAR in Environmental Research | journal | 0.513 Q3 | 54 | 47 | 112 | 1882 | 219 | 112 | 1.77 | 40.04 | 32.82 | |
94 | Journal of Natural Medicines | journal | 59 | 91 | 163 | 1737 | 48 | 162 | 0.35 | 19.09 | 28.90 | ||
93 | Methods in molecular medicine | book series | 0.496 Q3 | 59 | 187 | 926 | 805 | 1009 | 926 | 1.22 | 4.30 | 35.63 | |
92 | Infectious Disorders - Drug Targets | journal | 1.158 Q2 | 61 | 35 | 89 | 3848 | 270 | 83 | 2.97 | 109.94 | 29.17 | |
91 | Drug Discovery Today: Technologies | journal | 0.553 Q3 | 62 | 21 | 176 | 331 | 302 | 166 | 1.25 | 15.76 | 35.56 | |
90 | Assay and Drug Development Technologies | journal | 0.796 Q3 | 65 | 107 | 175 | 1707 | 354 | 167 | 1.85 | 15.95 | 31.37 | |
89 | Molecular Imaging | journal | 1.761 Q1 | 66 | 40 | 104 | 1348 | 433 | 85 | 2.86 | 33.70 | 33.06 | |
88 | Current Opinion in Molecular Therapeutics | journal | 0.985 Q2 | 67 | 72 | 238 | 4448 | 607 | 213 | 2.54 | 61.78 | 31.69 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®